Enable JavaScript to visit this website.

What is XELJANZ/XELJANZ XR?

Share your story and help other adults learn about your experiences with active psoriatic arthritis and XELJANZ/XELJANZ XR. Learning about your experience with XELJANZ/XELJANZ XR may be helpful for patients who are considering treatment or have already started. If chosen, your story may appear on XELJANZ.com and/or in other marketing materials.

IN ORDER TO SUBMIT YOUR STORY, YOU MUST:

  • Be age 18 or older
  • Be a resident of the United States
  • Have taken or currently be taking methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs)*
  • Have been diagnosed with active psoriatic arthritis
  • Have been taking XELJANZ or XELJANZ XR for your active psoriatic arthritis in combination with a nonbiologic DMARD*
  • Not be enrolled in a Pfizer clinical trial

*Methotrexate, Sulfasalazine or Leflunomide

Please answer at least one of the following three questions.

Why did you and your doctor decide to try XELJANZ/​XELJANZ XR

What impact has taking XELJANZ or XELJANZ XR had on your active psoriatic arthritis symptoms?

What advice do you have for other people living with active psoriatic arthritis?

ALL FIELDS REQUIRED UNLESS MARKED OPTIONAL

PRIVACY STATEMENT

Pfizer understands that your health is a personal matter and respects your privacy. Please review our Privacy Policy so that you may understand the information we collect about you, how we use and protect it, and the choices we offer you with respect to your personal information. The information you provide will be used by Pfizer and parties acting on its behalf to send you the materials you requested and other helpful information and updates on XELJANZ as well as related treatments, products, offers, and services. In addition, you understand that we or parties acting on our behalf may contact you regarding your story.